Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants

Background: Azvudine (FNC) is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). However, drug interactions with azvudine have been poorly studied, especially with no reported cases of azvudine with anticoagulants such as warfarin and rivaroxaban.Case summary: The pati...

Full description

Bibliographic Details
Main Authors: Xi Zhang, Fengwei Jiao, Guangrun Li, Xiaojia Yu, Yuqing Pei, Ying Zhang, Zihui Wang, Pengfei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
azvudine
warfarin
rivaroxaban
DDI
international normalized ratio (INR)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1191608/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1191608/full

Similar Items